Maternal Metabolic & Environmental Teratogens

Maternal metabolic conditions (diabetes, phenylketonuria, hyperthermia) and environmental physical exposures (radiation, recreational substances) disrupt fetal development through mechanisms distinct from drug-receptor binding or infectious tropism. Each acts on a recognizable timing window and produces a recognizable injury pattern. Of these, maternal diabetes is the most clinically prominent because it's the most common (and the fastest-rising clinical scenario), and maternal PKU is the most counter-intuitive (the mother is unaffected; the unborn child bears the entire burden).

The single most prevalent maternal metabolic teratogen. The mechanism is hyperglycemia → oxidative stress → embryonic apoptosis + altered gene expression, layered on top of disruption of yolk-sac and endothelial development.

Risk

• Pregestational diabetes (T1DM, T2DM): congenital malformation rate ~5–10% (vs. ~3% baseline) when poorly controlled. Risk correlates with periconceptional HbA1c: HbA1c <6.5% confers near-baseline risk; HbA1c >9% can carry malformation rates of 25–30%.
• Gestational diabetes: typically diagnosed at 24–28 weeks; does not produce embryopathy (organogenesis already complete) but causes macrosomia, neonatal hypoglycemia, polycythemia, polyhydramnios.

Diabetic embryopathy phenotype

• Caudal regression syndrome / sacral agenesis: near-pathognomonic. Spectrum from sacral dysgenesis to sirenomelia (fused lower limbs). Mechanism: failure of caudal mesoderm.
• Cardiac defects (~5× background): conotruncal lesions (transposition, truncus, tetralogy), VSD, ASD, hypoplastic left heart.
• Neural tube defects (~10× background): anencephaly, spina bifida.
• Renal anomalies: agenesis, dysplasia, hydronephrosis.
• Holoprosencephaly and microcephaly.
• Skeletal: hemivertebrae, femoral hypoplasia ("femoral hypoplasia-unusual facies syndrome").
• Macrosomia (separate from organogenesis-window damage; reflects hyperinsulinemia in the fetal period).

Counseling and Management

• Preconception is the high-leverage moment: target HbA1c <6.5% before attempting pregnancy. Multidisciplinary care (endocrinology, MFM, dietician).
• Folate 4 mg/day periconceptionally given the elevated NTD risk.
• Detailed anatomy ultrasound at 18–22 weeks; fetal echocardiogram at 22–24 weeks.
• Late-pregnancy monitoring for macrosomia, polyhydramnios, fetal well-being.

• Mechanism: maternal hyperphenylalaninemia in PKU mothers (themselves treated and well-controlled in childhood, but who often relax phe-restricted diet in adulthood) → elevated fetal phenylalanine → direct neurotoxicity to the developing brain.
• The fetus is heterozygous (typically), so the fetal PAH activity is normal, but the fetal brain still cannot escape the maternal phe load.
• Phenotype:
  • Microcephaly (most common)
  • Intellectual disability
  • Congenital heart defects (especially when phe levels are very high in early pregnancy; ~10% incidence with maternal phe >20 mg/dL)
  • IUGR
  • Characteristic facies (long philtrum, thin upper lip, overlapping with FAS phenotype)
• Counseling: identify women with PKU before pregnancy; restart strict phe-restricted diet preconceptionally with target maternal phe 2–6 mg/dL throughout pregnancy. The single most preventable form of intellectual disability outside of alcohol/iodine.

• Mechanism: elevated maternal core temperature (>38.9°C / 102°F) for sustained periods can disrupt neural tube closure (and, less commonly, other developmental events).
• Sources: maternal fever, prolonged hot tub / sauna use in early pregnancy.
• Risk window: weeks 3–4 (neural tube closure); declining risk after week 8.
• Outcome: increased risk of NTDs (~2–3× baseline). Antipyresis is sensible during febrile illness in early pregnancy.

• Mechanism: severe maternal iodine deficiency → maternal and fetal hypothyroidism → impaired neurodevelopment.
• Phenotype ("endemic cretinism"): severe intellectual disability, deafness, gait abnormalities, growth restriction.
• Globally, iodine deficiency is the leading preventable cause of intellectual disability (alcohol leads in iodine-replete countries).
• Universal salt iodization has dramatically reduced rates worldwide.

• Mechanism: DNA damage in dividing cells; effects depend on dose and gestational age.
• Threshold: clinically meaningful risk begins around 10–20 rad (100–200 mGy) of fetal exposure. Below this, the risk-benefit of diagnostic imaging is decisively favorable.
• Diagnostic imaging fetal doses:
  • Chest X-ray: <0.001 rad
  • Abdominal X-ray: ~0.1 rad
  • CT abdomen/pelvis: ~2.5 rad
  • PET/CT: ~1–2 rad
  • All are well below threshold.
• Therapeutic radiation (treating maternal cancer): can exceed threshold; requires careful dosimetry and shielding.
• Risk by gestational age:
  • Weeks 0–2: all-or-none.
  • Weeks 3–8 (organogenesis): above threshold causes microcephaly, growth restriction, structural malformation.
  • Weeks 8–25: above threshold causes IQ reduction proportional to dose.
  • All trimesters: small lifetime increase in childhood malignancy (~0.06% per rad).
• Diagnostic imaging is rarely a clinical concern. Reassurance with documentation is the appropriate response.

Tobacco

• Mechanism: nicotine vasoconstriction + carbon monoxide hypoxia → placental insufficiency.
• Effects: IUGR (single biggest preventable cause), preterm birth, placental abruption, increased risk of cleft lip/palate (modest), increased SIDS risk postnatally.
• No characteristic dysmorphism, but IUGR is consistent.

Cocaine and Stimulants

• Mechanism: vascular disruption from intense vasoconstriction → ischemia.
• Effects: placental abruption, preterm labor, fetal demise. Fetal injury patterns: limb-reduction defects (vascular disruption), cerebral infarction, gastroschisis (vascular origin), genitourinary anomalies. Methamphetamine has similar profile.
• Distinguishing feature: ischemic / vascular-disruption phenotype rather than direct teratogenesis.

Opioids

• Effects: not classically teratogenic (no characteristic dysmorphism), but cause neonatal abstinence syndrome (NAS): irritability, tremors, feeding difficulty, seizures in withdrawn newborn. Increased IUGR. Recent data suggest a small signal for cardiac defects with first-trimester opioid exposure.
• Treatment of opioid use disorder in pregnancy: maintenance therapy (methadone or buprenorphine) is the standard; abrupt cessation increases fetal demise risk.

Marijuana

• Limited data for major structural malformations. Concerns about neurodevelopmental effects from chronic THC exposure (executive function, attention) are growing. Not classically teratogenic in the structural sense.

Amniotic Band Sequence (Streeter dysplasia)

• Mechanism: rupture of amnion with fibrous strands wrapping fetal parts → constriction, amputation, deformation.
• Phenotype: irregular, asymmetric digit/limb amputations, constriction rings, atypical clefts (not following normal fusion lines), encephalocele in non-typical locations.
• Sporadic, non-genetic; recurrence risk near baseline. Critical to distinguish from genetic limb defects, which carry Mendelian recurrence risks.
• The asymmetry and irregularity are the giveaway.